Prolonged prevention of retinal degeneration with retinylamine loaded nanoparticles

Biomaterials

Volumn 44, Issue , 2015, Pages 103-110

  Puntel, Anthony ^a   Maeda, Akiko ^b   Golczak, Marcin ^b   Gao, Song Qi ^b   Yu, Guanping ^a   Palczewski, Krzysztof ^b   Lu, Zheng Rong ^a  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug delivery; Nanoparticles; Prevention; Retina degeneration; Retinylamine

Indexed keywords

ALDEHYDES; AMINES; CHROMOPHORES; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; MAMMALS; METABOLITES; NANOPARTICLES; OPHTHALMOLOGY; TARGETED DRUG DELIVERY;

AGE-RELATED MACULAR DEGENERATION; BIOCHEMICAL REACTIONS; HUMAN RETINAL DEGENERATIVE DISEASE; PREVENTION; RETINA DEGENERATION; RETINAL DEGENERATIONS; RETINAL DEGENERATIVE DISEASE; RETINYLAMINE;

DISEASES;

AMINE; NANOPARTICLE; POLYLACTIC ACID; RETINOID; RETINYLAMINE; UNCLASSIFIED DRUG; DITERPENE; LACTIC ACID; POLYMER;

AGE RELATED MACULAR DEGENERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA DEGENERATION; STARGARDT DISEASE; ANIMAL; CHEMISTRY; DRUG EFFECTS; ELECTRORETINOGRAPHY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIVER; METABOLISM; OPTICAL COHERENCE TOMOGRAPHY; PARTICLE SIZE; PATHOPHYSIOLOGY; RETINAL DEGENERATION; ULTRASTRUCTURE;

ANIMALIA; MUS;

ANIMALS; DITERPENES; ELECTRORETINOGRAPHY; HUMANS; IMMUNOHISTOCHEMISTRY; LACTIC ACID; LIVER; MICE, KNOCKOUT; NANOPARTICLES; PARTICLE SIZE; POLYMERS; RETINAL DEGENERATION; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84921268848     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.12.019     Document Type: Article

References (32)

1. Kiser PD, Golczak M, Palczewski K. Chemistry of the retinoid (visual) cycle. Chem Rev 114:194-232.
2. Wolf G. Anewly discovered visual cycle necessary for vision during continuous illumination. Nutr Rev 2002, 60:62-65.
3. Rando R.R. The biochemistry of the visual cycle. Chem Rev 2001, 101:1881-1896.
4. Palczewski K. Chemistry and biology of vision. J Biol Chem 287:1612-1619.
5. Maeda A., Maeda T., Golczak M., Palczewski K. Retinopathy in mice induced by disrupted all-trans-retinal clearance. JBiol Chem 2008, 283:26684-26693.
6. Maeda T, Golczak M, Maeda A. Retinal photodamage mediated by all-trans-retinal. Photochem Photobiol 88:1309-1319.
7. Chen Y, Okano K, Maeda T, Chauhan V, Golczak M, Maeda A, etal. Mechanism of all-trans-retinal toxicity with implications for Stargardt disease and age-related macular degeneration. J Biol Chem 287:5059-5069.
8. Sparrow J.R., Fishkin N., Zhou J., Cai B., Jang Y.P., Krane S., et al. A2E, a byproduct of the visual cycle. Vis Res 2003, 43:2983-2990.
9. Sparrow JR, Wu Y, Kim CY, Zhou J. Phospholipid meets all-trans-retinal: the making of RPE bisretinoids. J Lipid Res 51:247-261.
10. Mata N.L., Weng J., Travis G.H. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci U S A 2000, 97:7154-7159.
11. Murdaugh LS, Wang Z, Del Priore LV, Dillon J, Gaillard ER. Age-related accumulation of 3-nitrotyrosine and nitro-A2E in human Bruch's membrane. Exp Eye Res 90:564-571.
12. Maeda A., Golczak M., Chen Y., Okano K., Kohno H., Shiose S., et al. Primary amines protect against retinal degeneration in mouse models of retinopathies. Nat Chem Biol 2012, 8:170-178.
13. Kubota R, Boman NL, David R, Mallikaarjun S, Patil S, Birch D. Safety and effect on rod function of ACU-4429, a novel small-molecule visual cycle modulator. Retina 32:183-188.
14. Golczak M., Maeda A., Bereta G., Maeda T., Kiser P.D., Hunzelmann S., et al. Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina. JBiol Chem 2008, 283:9543-9554.
15. Golczak M., Kuksa V., Maeda T., Moise A.R., Palczewski K. Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle. Proc Natl Acad Sci U S A 2005, 102:8162-8167.
16. Zhang K., Zhang L., Weinreb R.N. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov 2012, 11:541-559.
17. Gaudana R., Jwala J., Boddu S.H., Mitra A.K. Recent perspectives in ocular drug delivery. Pharm Res 2009, 26:1197-1216.
18. Kompella U.B., Amrite A.C., Pacha Ravi R., Durazo S.A. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog Retin Eye Res 2013, 36:172-198.
19. Sun H. Membrane receptors and transporters involved in the function and transport of vitamin A and its derivatives. Biochim Biophys Acta 2012, 1821:99-112.
20. Yu G., Wu X., Ayat N., Maeda A., Gao S.Q., Golczak M., et al. Multifunctional PEG retinylamine conjugate provides prolonged protection against retinal degeneration in mice. Biomacromolecules 2014, 15:4570-4578.
21. Lee S.S., Hughes P., Ross A.D., Robinson M.R. Biodegradable implants for sustained drug release in the eye. Pharm Res 2010, 27:2043-2053.
22. Deng D., Wang W., Wang B., Zhang P., Zhou G., Zhang W.J., et al. Repair of Achilles tendon defect with autologous ASCs engineered tendon in a rabbit model. Biomaterials 2014, 35:8801-8809.
23. Deng Y., Saucier-Sawyer J.K., Hoimes C.J., Zhang J., Seo Y.E., Andrejecsk J.W., et al. The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles. Biomaterials 2014, 35:6595-6602.
24. Alvarez Z., Castano O., Castells A.A., Mateos-Timoneda M.A., Planell J.A., Engel E., et al. Neurogenesis and vascularization of the damaged brain using a lactate-releasing biomimetic scaffold. Biomaterials 2014, 35:4769-4781.
25. Ye F., Barrefelt A., Asem H., Abedi-Valugerdi M., El-Serafi I., Saghafian M., et al. Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging. Biomaterials 2014, 35:3885-3894.
26. Ma X., Cheng Z., Jin Y., Liang X., Yang X., Dai Z., et al. SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy. Biomaterials 2014, 35:2878-2889.
27. Zhang X., Dong Y., Zeng X., Liang X., Li X., Tao W., et al. The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment. Biomaterials 2014, 35:1932-1943.
28. Golczak M., Imanishi Y., Kuksa V., Maeda T., Kubota R., Palczewski K. Lecithin:retinol acyltransferase is responsible for amidation of retinylamine, a potent inhibitor of the retinoid cycle. JBiol Chem 2005, 280:42263-42273.
29. Mathaes R., Winter G., Besheer A., Engert J. Influence of particle geometry and PEGylation on phagocytosis of particulate carriers. Int J Pharm 2014, 465:159-164.
30. Molday R.S., Beharry S., Ahn J., Zhong M. Binding of N-retinylidene-PE to ABCA4 and a model for its transport across membranes. Adv Exp Med Biol 2006, 572:465-470.
31. Rattner A., Smallwood P.M., Nathans J. Identification and characterization of all-trans-retinol dehydrogenase from photoreceptor outer segments, the visual cycle enzyme that reduces all-trans-retinal to all-trans-retinol. JBiol Chem 2000, 275:11034-11043.
32. Maeda A., Maeda T., Golczak M., Chou S., Desai A., Hoppel C.L., et al. Involvement of all-trans-retinal in acute light-induced retinopathy of mice. JBiol Chem 2009, 284:15173-15183.